![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Perry John F Strasser Simone I George Jacob Farrell Geoffrey C McCaughan Geoffrey W
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2175-2185
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting integrins in hepatocellular carcinoma
By Wu Yanhua Qiao Xiaojing Qiao Shouyi Yu Long
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 4, 2011-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Contemporary management of hepatocellular carcinoma
Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sorafenib: In Hepatocellular Carcinoma
By Simpson Dene Keating Gillian M.
Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. :